Association Between Preadmission Acid Suppressive Medication Exposure and Severity of Illness in Patients Hospitalized With COVID-19. Gastroenterology 2021 Mar;160(4):1417-1422.e14
Date
11/16/2020Pubmed ID
33189702Pubmed Central ID
PMC7659802DOI
10.1053/j.gastro.2020.11.007Scopus ID
2-s2.0-85102113444 (requires institutional sign-in at Scopus site) 11 CitationsAuthor List
Elmunzer BJ, Wolf BJ, Scheiman JM, Tierney WM, Taylor JR, North American Alliance for the Study of Digestive Manifestations of COVID-19Authors
Kulwinder S. Dua MD Professor in the Medicine department at Medical College of WisconsinJames Esteban MD Assistant Professor in the Medicine department at Medical College of Wisconsin
Zachary Smith DO Associate Professor in the Medicine department at Medical College of Wisconsin
MESH terms used to index this publication - Major topics in bold
AdultAged
Female
Histamine H2 Antagonists
Hospitalization
Humans
Male
Middle Aged
Proton Pump Inhibitors
Retrospective Studies
Severity of Illness Index